PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice-Reference-Cited by-同舟云学术

PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice

Published:2019-01 Issue: Volume:161 Page:134-143
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Xia Yuchen^ORCID,Schlapschy Martin,Morath Volker^ORCID,Roeder Natalie,Vogt Elisabeth I.,Stadler Daniela^ORCID,Cheng Xiaoming,Dittmer Ulf,Sutter Kathrin,Heikenwalder Mathias,Skerra Arne,Protzer Ulrike^ORCID

Funder

CSC

German Research Foundation

Institute for Advanced Study

EU 7th Framework Programme

ERC

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference44 articles.

1. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome;Belloni;J. Clin. Invest.,2012

2. PASylation®: a versatile technology to extend drug delivery;Binder;Curr. Opin. Colloid Interface Sci.,2017

3. Involvement of the kidney in catabolism of human leukocyte interferon;Bino;J. Gen. Virol.,1982

4. Pharmacokinetics and tissue distribution of recombinant human alpha A, D, A/D(Bgl), and I interferons and mouse alpha-interferon in mice;Bohoslawec;J. Interferon Res.,1986

5. Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents;Garay;Expert Opin. Drug Deliv.,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions;Progress in Polymer Science;2024-09

2. Hepatitis B virus RNAs co-opt ELAVL1 for stabilization and CRM1-dependent nuclear export;PLOS Pathogens;2024-02-02

3. An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes;Emerging Microbes & Infections;2024-01-22

4. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy;Antiviral Research;2024-01

5. Polypeptides as alternatives to PEGylation of therapeutic agents;Expert Opinion on Drug Delivery;2023-12-25